Caelyx Injection -KR (Pegylated Liposomal Doxorubicin Hydrochloride Vials) 20mg/10ml

Caelyx Injection-KR (pegylated liposomal doxorubicin hydrochloride) is a chemotherapy formulation used for cancer treatment. Administered via infusion, it delivers targeted therapy with reduced side effects compared to conventional doxorubicin. Store at 2-8°C to maintain stability. Consult a healthcare provider for suitability.

Strength

20mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Janssen Korea Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pegylated liposomal doxorubicin hydrochloride is used to treat various cancers, including metastatic breast cancer and ovarian cancer. It may also be prescribed for AIDS-related Kaposi’s sarcoma when other treatments are ineffective. This formulation helps deliver chemotherapy directly to tumor sites while minimizing exposure to healthy tissues.

Side Effects

Common effects include hair thinning, nausea, and fatigue during treatment. Some patients experience mouth sores or changes in blood cell counts. Skin reactions at the infusion site may occur. These effects vary by individual and are typically monitored by a healthcare team.

Precautions & Warnings

Store vials refrigerated between 2-8°C and protect from light. Avoid freezing. Handle with care to prevent accidental exposure; use gloves and dispose of properly. Inform your doctor of any allergies or prior chemotherapy reactions before starting treatment.

Avoid Interactions

This medication may interact with other chemotherapy drugs, CYP3A4 inhibitors, or live vaccines. Alcohol and certain herbal supplements could affect its efficacy or increase side effects. Always disclose all medications and supplements to your healthcare provider before use.

Frequently Asked Questions

It is used to treat certain cancers, including metastatic breast cancer, ovarian cancer, and AIDS-related Kaposi’s sarcoma.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Online purchase may be restricted; consult a licensed pharmacy or healthcare provider for availability.

Common side effects include hair thinning, nausea, fatigue, and mouth sores.

Store refrigerated between 2-8°C and protect from light; do not freeze.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.